Asmavent Nebulizing Solution
Formulation
Each mL nebulizing suspension contains:
Budesonide 250 mcg

Budesonide

Asmavent® Nebulizing Solution

Prescription Drug

Indication

  • For the chronic control of signs and symptoms of bronchial asthma
  • For the maintenance treatment of asthma and as prophylactic therapy in adults and children
  • For the management of childhood croup

Budesonide inhalation is NOT indicated for the relief of acute bronchospasm

Dosage and Administration

For more information on safety, precaution and other information about this product, please see the Product Insert.

Please consult your physician and other healthcare providers before taking any prescription medicines found on this site. The contents found on this page are for information purposes only. It should not be construed as a substitute for professional medical advise and should not be relied upon in that regard. You undertake to carefully read all product packaging and labels prior to use.

Caution: Food, Drugs, Devices and Cosmetics Act prohibits dispensing without prescription.